Magnus Financial Group’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-928
| Closed | -$589K | – | 392 |
|
|
2025
Q1 | $589K | Sell |
928
-213
| -19% | -$147K | 0.06% | 199 |
|
|
2024
Q4 | $813K | Sell |
1,141
-447
| -28% | -$375K | 0.08% | 167 |
|
|
2024
Q3 | $1.67M | Buy |
1,588
+20
| +1% | +$22.3K | 0.17% | 103 |
|
|
2024
Q2 | $1.65M | Buy |
1,568
+1
| +0.1% | +$969 | 0.19% | 95 |
|
|
2024
Q1 | $1.51M | Buy |
1,567
+8
| +0.5% | +$7.61K | 0.18% | 99 |
|
|
2023
Q4 | $1.37M | Buy |
1,559
+3
| +0.2% | +$2.47K | 0.18% | 94 |
|
|
2023
Q3 | $1.28M | Buy |
1,556
+150
| +11% | +$118K | 0.19% | 87 |
|
|
2023
Q2 | $1.01M | Sell |
1,406
-110
| -7% | -$84.8K | 0.14% | 110 |
|
|
2023
Q1 | $1.25M | Buy |
1,516
+15
| +1% | +$11.3K | 0.19% | 93 |
|
|
2022
Q4 | $1.08M | Sell |
1,501
-6
| -0.4% | -$4.43K | 0.18% | 96 |
|
|
2022
Q3 | $1.04M | Buy |
1,507
+492
| +48% | +$310K | 0.2% | 91 |
|
|
2022
Q2 | $600K | Buy |
1,015
+16
| +2% | +$10.4K | 0.11% | 138 |
|
|
2022
Q1 | $698K | Buy |
999
+14
| +1% | +$8.86K | 0.12% | 134 |
|
|
2021
Q4 | $622K | Buy |
985
+37
| +4% | +$22.7K | 0.12% | 121 |
|
|
2021
Q3 | $574K | Buy |
948
+35
| +4% | +$21.7K | 0.12% | 116 |
|
|
2021
Q2 | $510K | Buy |
913
+170
| +23% | +$86.1K | 0.11% | 125 |
|
|
2021
Q1 | $352K | Sell |
743
-202
| -21% | -$98.3K | 0.09% | 159 |
|
|
2020
Q4 | $457K | Sell |
945
-622
| -40% | -$336K | 0.05% | 156 |
|
|
2020
Q3 | $877K | Sell |
1,567
-107
| -6% | -$64.9K | 0.1% | 78 |
|
|
2020
Q2 | $1.04M | Buy |
1,674
+694
| +71% | +$394K | 0.12% | 68 |
|
|
2020
Q1 | $479K | Sell |
980
-322
| -25% | -$133K | 0.07% | 151 |
|
|
2019
Q4 | $489K | Buy |
+1,302
| New | +$438K | 0.07% | 151 |
|
|
2019
Q3 | – | Sell |
-1,386
| Closed | -$434K | – | 578 |
|
|
2019
Q2 | $434K | Buy |
1,386
+482
| +53% | +$160K | 0.08% | 136 |
|
|
2019
Q1 | $371K | Buy |
904
+18
| +2% | +$7.41K | 0.08% | 163 |
|
|
2018
Q4 | $331K | Buy |
+886
| New | +$324K | 0.09% | 156 |
|
Other funds holding REGN
